# Phase 4 recurrence trials recruiting: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 4 for recurrence that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 recurrence trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/recurrence

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 14, 2026 | NCT07766122 | Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU | University Hospital, Toulouse | Phase 4 | Not yet recruiting | Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766122) |
| December 17, 2025 | NCT07288801 | Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women | Nishtar Medical University | Phase 4 | Recruiting | Pre-eclampsia, Pregnancy, Vitamin D | 146 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07288801) |
| October 1, 2025 | NCT07200336 | Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP | Eye & ENT Hospital of Fudan University | Phase 4 | Not yet recruiting | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07200336) |
| September 22, 2025 | NCT07186465 | Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis | Mahidol University | Phase 4 | Recruiting | Cystitis, Recurrent, Urinary Tract Infections | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07186465) |
| September 15, 2025 | NCT07174076 | Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease | Sponsor not shown (see the record) | Phase 4 | Recruiting | Mycobacterium Avium Complex Pulmonary Disease | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07174076) |
| June 10, 2025 | NCT07013838 | The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis | Chinese SLE Treatment And Research Group | Phase 4 | Not yet recruiting | Takayasu Arteritis (TAK) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013838) |
| January 17, 2025 | NCT06781879 | Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer | Sponsor not shown (see the record) | Phase 4 | Recruiting | Non-Muscle Invasive Bladder Cancer | 272 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06781879) |
| January 7, 2025 | NCT06761911 | BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Hodgkin Lymphoma (Category) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06761911) |
| August 9, 2024 | NCT06546475 | A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine | National Taiwan University Hospital | Phase 4 | Not yet recruiting | Psychosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06546475) |
| June 21, 2024 | NCT06468709 | A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of Recurrence | Ruijin Hospital | Phase 4 | Recruiting | Type 1 AIP | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06468709) |
| April 1, 2024 | NCT06339775 | Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation | Sponsor not shown (see the record) | Phase 4 | Recruiting | Acute B-cell Lymphoblastic Leukemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06339775) |
| March 26, 2024 | NCT06330038 | Anesthesia and Non-small Cell Lung Cancer Recurrence | Samsung Medical Center | Phase 4 | Recruiting | Non-small Cell Lung Cancer, Surgery, Anesthesia | 5,384 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06330038) |
| March 15, 2024 | NCT06311916 | Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model. | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | HCC | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06311916) |
| February 9, 2024 | NCT06251076 | Plan Development for Giving Teclistamab in the Outpatient Setting | University Health Network, Toronto | Phase 4 | Recruiting | Multiple Myeloma, Relapsed Cancer, Refractory Cancer | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06251076) |
| October 19, 2023 | NCT06090994 | Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy | Fudan University | Phase 4 | Recruiting | Colorectal Cancer | 756 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06090994) |
| June 7, 2023 | NCT05892744 | Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression | University of Texas at Austin | Phase 4 | Recruiting | Major Depressive Disorder, Chronic Major Depression, Recurrent | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05892744) |
| April 18, 2023 | NCT05814848 | A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma | Changhai Hospital | Phase 4 | Not yet recruiting | Relapsed or Refractory B-cell Lymphoma | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05814848) |
| April 10, 2023 | NCT05806580 | Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma | Ruijin Hospital | Phase 4 | Recruiting | Relapsed or Refractory B-cell Lymphoma | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05806580) |
| July 18, 2022 | NCT05461820 | Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease | The First Affiliated Hospital with Nanjing Medical University | Phase 4 | Recruiting | Graves Disease, Relapse, Treatment, Drug Withdrawal | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05461820) |
| January 12, 2021 | NCT04704999 | Southeast Asia Dose Optimization of Tafenoquine | University of Oxford | Phase 4 | Recruiting | Plasmodium Vivax Malaria | 820 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04704999) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Ruijin Hospital | 2 |
| University of Oxford | 1 |
| Samsung Medical Center | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
| National Taiwan University Hospital | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| University Health Network, Toronto | 1 |
| University of Texas at Austin | 1 |
| Changhai Hospital | 1 |
| Nishtar Medical University | 1 |
| Mahidol University | 1 |
| University Hospital, Toulouse | 1 |
| Fudan University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 8 |
| Thailand | 2 |
| Cambodia | 1 |
| Indonesia | 1 |
| Laos | 1 |
| Vietnam | 1 |
| South Korea | 1 |
| Canada | 1 |
| Denmark | 1 |
| Iceland | 1 |
| Norway | 1 |
| Sweden | 1 |
| United States | 1 |
| Pakistan | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Immunodermatology practices in the United States](https://specstream.ai/data/businesses/immunodermatology-practices/united-states)
- [HVAC contractors in the United States](https://specstream.ai/data/businesses/hvac-contractors/united-states)
- [Hospitals in the United States](https://specstream.ai/data/businesses/hospitals/united-states)
- [Home insurance agencies in the United States](https://specstream.ai/data/businesses/home-insurance-agencies/united-states)
- [Hematology practices in the United States](https://specstream.ai/data/businesses/hematology-practices/united-states)
- [Haitian restaurants in the United States](https://specstream.ai/data/businesses/haitian-restaurants/united-states)
